课题基金 / 基金详情

Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil

Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
美国和巴西不同群体神经病理特征的全基因组测序和混合分析
批准号:
10590405
负责人:
DAVID ALAN BENNETT
金额:
$367.18万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-15 至 2028-07-31

项目摘要

项目成果

DAVID ALAN BENNETT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Identifying molecular drivers of Alzheimer’s disease and related dementias (AD/ADRD) pathologies is an urgent public health priority. This is especially important in persons of African Ancestry. The overall goal of the proposed study is to identify genes and proteins that drive common AD/ADRD pathologic traits. We previously used multi-level omics to identify molecular drivers of AD/ADRD pathologic traits in non-Latinx whites. The proposed study, submitted in response to NOT-AG-18-053 will extend this work by leveraging an unique, ongoing, diverse study being conducted in Sao Paulo, Brazil, called “Pathology, Alzheimer´s and Related Dementias Study” (PARDoS) and five other diverse cohorts in the USA, with whole genome sequencing (WGS) on more than 1350 diverse autopsied participants. PARDoS is prospectively generating neuropathologic and clinical AD/ADRD traits, and DNA on admixed Brazilians of European and African, and to a lesser extent Native Brazilian ancestry. The proposal has the following Aims. Aim 1 will generate WGS on an additional 7650 persons in collaboration with the Alzheimer’s Disease Sequencing Project (ADSP). Aim 2 will perform deep admixture mapping of known SNPs for Alzheimer’s dementia, to determine their associations with AD/ADRD neuropathologic phenotypes in 6500 admixed Brazilian brains followed generalization to 300 diverse brains from the USA, and discovery analyses for 5500 Brazilians followed by generalization to 2000 diverse samples in the USA. Aim 3 will computationally determine telomere length (TL) and examine their association with AD/ADRD clinical and pathologic traits. An exploratory analysis will examine for rare variant associations with AD/ADRD neuropathologic traits. Aim 5 will examine the association of mitochondrial DNA to AD/ADRD traits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations
  • 批准号:
    10655203
  • 项目类别:
  • 资助金额:
    $32.1万
  • 财政年份:
    2023
  • 负责人:
    DAVID ALAN BENNETT
  • 依托单位:
Core H: Religious Orders Study Core
  • 批准号:
    10264500
  • 项目类别:
  • 资助金额:
    $70.65万
  • 财政年份:
    2021
  • 负责人:
    DAVID ALAN BENNETT
  • 依托单位:
Core A: Administrative Core
  • 批准号:
    10472763
  • 项目类别:
  • 资助金额:
    $26.61万
  • 财政年份:
    2021
  • 负责人:
    DAVID ALAN BENNETT
  • 依托单位:
Core A: Administrative Core
  • 批准号:
    10264494
  • 项目类别:
  • 资助金额:
    $26.61万
  • 财政年份:
    2021
  • 负责人:
    DAVID ALAN BENNETT
  • 依托单位:
海外基金